• Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
• New myExam 3D Camera contains features to accelerate clinical workflow
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the YSIO X.pree, a ceiling-mounted radiography system with the MyExam Companion intelligent user interface. In addition to this easy-to-use interface that guides the radiologic technologist through the exam workflow, the YSIO X.pree has a new 3D camera for patient positioning and advanced collimation, as well as a new smart image processing engine. With these features, the YSIO X.pree improves the user and patient experience in addition to optimizing clinical operations to transform the delivery of care.
The YSIO X.pree is the first radiography system to feature the MyExam Companion user interface, which provides proactive guidance to help technologists of any skill level navigate a radiography procedure. MyExam Companion combines available patient data such as gender and age with other user or machine-observable, patient-specific information to identify optimal acquisition and reconstruction parameters for each patient and radiography procedure. These innovations increase the efficiency of the imaging process.
The system’s new MyExam 3D camera helps speed up the clinical workflow. Its Virtual Collimation feature permits technologists to precisely adjust the size and shape of the X-ray beam via the touchscreen monitor and reduce the volume of irradiated patient tissue. The camera-based Smart Virtual Ortho functionality enables shorter preparation times for orthopedic multi-image acquisitions. With Smart Virtual Ortho, the user can set the field of view and adjust exposure parameters on the touchscreen with the aid of a live camera image of the patient, making long-leg and full-spine examinations faster and easier to perform. The camera’s Auto Thorax Collimation feature used automated, AI-based body-part detection and collimation to accelerate thorax examination workflows by analyzing the patient’s body contour and adjusting the collimator blades in less than half a second.
The YSIO X.pree is also more ergonomically designed than predecessor systems. In addition to its adjustable touch display, it has an adjustable tube touchscreen monitor that is positioned lower than monitors on previous ceiling-mounted units.
The system’s new image processing database is designed to deliver image consistency. Technologists can use the intelligent dynamic range optimization to set preferred image contrasts. Intelligent noise elimination removes image noise and enables low-dose settings for all clinical tasks, and gridless acquisition for free exposures limits the need for additional patient radiation dose. AI-based cropping is designed to produce well-cropped images each time.
“The YSIO X.pree ceiling-mounted radiography system represents a dramatic leap forward in intelligent X-ray imaging, providing our customers with an unprecedented level of intuitive operation for consistent X-ray images and potentially faster workflow,” said Niral Patel, Vice President of X-Ray Products at Siemens Healthineers North America.
Contact for journalists
Jeff Bell
Phone: +484 868-8346; E-mail: jeffrey.t.bell@siemens-healthineers.com
For further information on the YSIO X.pree, please see
https://siemens-healthineers.com/ysio-xpree
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers’ worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance the healthcare provider’s ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.
Further information is available at www.siemens-healthineers.com.
